![Detection of circulating tumour cells before and following adjuvant chemotherapy and long-term prognosis of early breast cancer | British Journal of Cancer Detection of circulating tumour cells before and following adjuvant chemotherapy and long-term prognosis of early breast cancer | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-022-01699-5/MediaObjects/41416_2022_1699_Fig1_HTML.png)
Detection of circulating tumour cells before and following adjuvant chemotherapy and long-term prognosis of early breast cancer | British Journal of Cancer
![Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial - The Lancet Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/4b7e768e-047f-4bfb-834a-78ab10e744e8/gr2_lrg.jpg)
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial - The Lancet
![Combination of gefitinib and methotrexate to treat tubal ectopic pregnancy (GEM3): a multicentre, randomised, double-blind, placebo-controlled trial - The Lancet Combination of gefitinib and methotrexate to treat tubal ectopic pregnancy (GEM3): a multicentre, randomised, double-blind, placebo-controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/2d7ab7e8-6065-4744-b7d3-4b10e65cd978/gr1_lrg.jpg)